Elanco Animal Health Inc (ELAN) revenue & profit
Elanco Animal Health Inc (ELAN): revenue $4.7B, net income -$232M in 2025; latest quarter +10.2% year over year. From SEC filings.
$4.7BRevenue 2025
TickerELAN (NYSE)
IndustryHealthcare · Pharmaceutical Preparations
Revenue 2025$4.7B
Net income 2025-$232M
Net margin-4.9%
Annual revenue growth+6.2%
Latest quarter (2026 Q2) · Revenue$1.4B
vs. same quarter last year+10.2%
Latest quarter · Net income$54M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $4.4B | -$78M | |
| 2023 | $4.4B | -$1.2B | |
| 2024 | $4.4B | $338M | |
| 2025 | $4.7B | -$232M |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.